Shanxi Province Cancer Hospital

• NCT07682376

  Collaborator, Phase 2, Active, not recruiting, 96 people, 2 Jul 2026

• NCT07646145

  Phase 2, Recruiting, 30 people, 12 Jun 2026

• NCT07586826

  Collaborator, Phase 2, Recruiting, 220 people, 14 May 2026

• NCT07586813

  Collaborator, Phase 2, Recruiting, 220 people, 14 May 2026

• NCT07383285

  Collaborator, Phase 2, Not yet recruiting, 106 people, 3 Feb 2026

• dCRT vs. Surgery in Resectable ESCC Patients Achieving cCR/PR After Induction Chemoimmunotherapy

  Collaborator, Phase 2, Recruiting, 120 people, 9 Sept 2025

• NCT07083375

  Collaborator, Phase 2, Not yet recruiting, 56 people, 24 Jul 2025

• NCT06195228

  Collaborator, Phase 4, Recruiting, 800 people, 8 Jan 2024

• NCT05900921

  Collaborator, Phase 2, Status unknown, 132 people, 13 Jun 2023

• NCT04807673

  Collaborator, Phase 3, Recruiting, 342 people, 19 Mar 2021

• NCT04715217

  Phase 1/2, Status unknown, 24 people, 20 Jan 2021

• NCT04714827

  Phase 1/2, Status unknown, 24 people, 19 Jan 2021

• NCT04714593

  Phase 1/2, Status unknown, 24 people, 19 Jan 2021

• NCT02459457

  Collaborator, Phase 3, Completed, 321 people, 2 Jun 2015

• NCT01501136

  Collaborator, Phase 4, Status unknown, 200 people, 29 Dec 2011

Sources: clinicaltrials.gov